No photo of Ingemar Merkies

Ingemar Merkies

20192020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Activities of daily living in myotonic dystrophy type 1

Landfeldt, E., Nikolenko, N., Jimenez-Moreno, C., Cumming, S., Monckton, D. G., Faber, C. G., Merkies, I. S. J., Gorman, G., Turner, C. & Lochmueller, H., May 2020, In : Acta Neurologica Scandinavica. 141, 5, p. 380-387 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

A gain-of-function sodium channel beta 2-subunit mutation in painful diabetic neuropathy

Alsaloum, M., Estacion, M., Almomani, R., Gerrits, M. M., Boenhof, G. J., Ziegler, D., Malik, R., Ferdousi, M., Lauria, G., Merkies, I. S. J., Faber, C. G., Dib-Hajj, S., Waxman, S. G., de Greef, B., Hoeijmakers, J. G. J., Sopacua, M., Smeets, H. J. M., Vanoevelen, J. M., Eijkenboom, Lindsey, P. & 21 others, Almomani, R., Taiana, M., Marchi, M., Lombardi, R., Cazzato, D., Boneschi, F. M., Zauli, A., Clarelli, F., Santoro, S., Lopez, A. B., Quattrini, A., Cestele, S., Chever, O., Tavakoli, M., Malik, R., Kapetis, D., Xenakis, M. N., Mantegazza, M., Battiato, F., Strom, A. & PROPANE Study Grp, May 2019, In : Molecular Pain. 15, p. 1-14 14 p., 1744806919849802.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

IqYmune (R) is an effective maintenance treatment for multifocal motor neuropathy: A randomised, double-blind, multi-center cross-over non-inferiority study vs Kiovig (R)-The LIME Study

Leger, J-M., Cisse, O. A., Cocito, D., Grouin, J-M., Katifi, H., Nobile-Orazio, E., Ouaja, R., Pouget, J., Rajabally, Y. A., Sevilla, T. & Merkies, I. S. J., Mar 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 56-63 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Lacosamide in patients with Na(v)1.7 mutations-related small fibre neuropathy: a randomized controlled trial

de Greef, B. T. A., Hoeijmakers, J. G. J., Geerts, M., Oakes, M., Church, T. J. E., Waxman, S. G., Dib-Hajj, S. D., Faber, C. G. & Merkies, I. S. J., Feb 2019, In : Brain. 142, p. 263-275 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP PATH extension study

van Schaik, I. N., Mielke, O., Bril, V., van Geloven, N., Hartung, H-P., Lewis, R. A., Sobue, G., Lawo, J-P., Praus, M., Durn, B. L., Cornblath, D. R., Merkies, I. S. J., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J. & 31 others, Larue, S., D'Amour, C., Bril, V., Breiner, A., Kunc, P., Michal, M., Sussova, J., Tomas, K., Talab, R., Michal, B., Toomsoo, T., Rubanovits, Gross-Paju, K., Sorro, U., Saarela, M., Auranen, M., Pouget, J., Attarian, S., Le Masson, G., Wielanek-Bachelet, A., Desnuelle, C., Delmont, E., Clavelou, P., Aufauvre, D., Schmidt, J., Mori, M., Visser, N., Faber, C., Hoeijmakers, J., Allen, J. & PATH Study Grp, Sep 2019, In : Neurology: Neuroimmunology & Neuroinflammation. 6, 5, 13 p., 590.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access